Otros idiomas Diagonal Bio AB

Acciones

DIABIO

SE0015961826

Mercado cerrado - Nasdaq Stockholm Otros sitios de cotización 17:23:34 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
0,0752 ^SEK	-5,41 %		-13,96 %	-78,70 %

05/04	Diagonal Bio AB (publ) anuncia la ampliación de su asociación con la Clínica Veterinaria Horsholm	CI
05/04	Diagonal Bio AB (publ) anuncia el éxito del estudio piloto	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Diagonal Bio AB announces outcome of rights issue	24/04
Diagonal Bio AB publish - White paper	16/04
Diagonal Bio AB strengthens its go-to-market strategy through an agreement with founding partner Johan Källstrand	10/04
The subscription period in Diagonal Bio AB rights issue commences today	08/04
Diagonal Bio announces successful pilot study results and extended partnership with Hørsholm Veterinary Clinic	05/04
Diagonal Bio AB Announces the Extension of Its Partnership with Horsholm Veterinary Clinic	05/04
Diagonal Bio AB Announces Successful Pilot Study Results	05/04
Diagonal Bio AB publishes a prospectus because of upcoming rights issue	03/04
Bulletin from the Extraordinary General Meeting on Tuesday 2[nd] of April in Diagonal Bio AB	02/04
Diagonal Bio Makes Interim CEO Permanent	29/02
Diagonal Bio appoints Karin Wehlin as new CEO	28/02
Diagonal Bio Appoints Karin Wehlin as New CEO	28/02
Notice to attend the extraordinary general meeting of Diagonal Bio AB	28/02
The Board of Directors decides on a preferential rights issue of units in order to finance future development	28/02
Diagonal Bio AB Year-end Report 2023	28/02
Diagonal Bio AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	28/02
Diagonal Bio Signs Product Distribution Deal With Techtum Lab	16/02
Diagonal Bio AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	31/10/23
Diagonal Bio AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	22/08/23
Diagonal Bio AB announced that it expects to receive SEK 1.8 million in funding	22/08/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Diagonal Bio AB

Acciones

DIABIO

SE0015961826

Otros idiomas

Filtros